SNY logo

SNY
Sanofi-Aventis

5,547
Mkt Cap
$120.78B
Volume
3.34M
52W High
$60.12
52W Low
$44.62
PE Ratio
12.34
SNY Fundamentals
Price
$49.70
Prev Close
$48.89
Open
$49.52
50D MA
$49.29
Beta
0.25
Avg. Volume
2.87M
EPS (Annual)
$2.40
P/B
1.47
Rev/Employee
$525,340.04
Loading...
Loading...
News
all
press releases
Sanofi $SNY Shares Bought by Willis Investment Counsel
Willis Investment Counsel grew its position in Sanofi (NASDAQ:SNY - Free Report) by 56.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The...
MarketBeat·8h ago
News Placeholder
More News
News Placeholder
Westfield Capital Management Co. LP Trims Stake in Sanofi $SNY
Westfield Capital Management Co. LP decreased its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 12.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·8h ago
News Placeholder
Frank Rimerman Advisors LLC Invests $261,000 in Sanofi $SNY
Frank Rimerman Advisors LLC bought a new stake in Sanofi (NASDAQ:SNY - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...
MarketBeat·10h ago
News Placeholder
Brandywine Global Investment Management LLC Boosts Stock Holdings in Sanofi $SNY
Brandywine Global Investment Management LLC grew its position in Sanofi (NASDAQ:SNY - Free Report) by 0.9% during the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·11h ago
News Placeholder
Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug
Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement with Pfizer and Tris over quality issues in children's medication.read more...
Benzinga·1d ago
News Placeholder
Primecap Management Co. CA Boosts Stake in Sanofi $SNY
Primecap Management Co. CA raised its position in Sanofi (NASDAQ:SNY - Free Report) by 3.2% during the second quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·1d ago
News Placeholder
Avantax Advisory Services Inc. Boosts Stock Holdings in Sanofi $SNY
Avantax Advisory Services Inc. raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 10.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund...
MarketBeat·2d ago
News Placeholder
REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD
Regeneron gains EC approval to expand Libtayo's use in high-risk CSCC. The FDA approves Eylea HD the treatment of patients with macular edema following retinal vein occlusion.
Zacks·2d ago
News Placeholder
Sanofi $SNY Stock Holdings Trimmed by Dorsey & Whitney Trust CO LLC
Dorsey & Whitney Trust CO LLC decreased its holdings in Sanofi (NASDAQ:SNY - Free Report) by 20.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The...
MarketBeat·3d ago
News Placeholder
Creative Planning Sells 55,044 Shares of Sanofi $SNY
Creative Planning decreased its position in Sanofi (NASDAQ:SNY - Free Report) by 20.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission...
MarketBeat·4d ago

Latest SNY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.